Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
February 4, 2013 - (Stem Cell Therapeutics) - "Stem Cell Therapeutics Corp., a life sciences company developing stem cell-related technologies, today announced the execution of a Letter of Agreement with Trillium Therapeutics Inc. ("Trillium") of Toronto, under which Trillium would be merged into Stem Cell Therapeutics Corp. by way of a three-cornered amalgamation or plan of arrangement with a newly-created SCT subsidiary." Read Full Press Release
